PubMed Health⌕ Search

Biomedical subjects

C Engelking

Publications and source records attributed to C Engelking.

28 records · Page 2Linked to original sources

Treatment of advanced prostate cancer with cyclophosphamide, doxorubicin, and methotrexate.

Twenty-three patients with advanced prostate cancer who had failed previous hormone therapy were treated with cyclophosphamide, doxorubicin, and methotrexate on a 3-week course. Of the 22 evaluable patients, over one-half had poor performance status, increased acid and alkaline phosphatase levels, and pain. Parameters which improved in greater than 50% of cases included acid and alkaline phosphatase levels, pain, performance status, and measurable lesions (lung and soft tissue). Initial parameters associated with a significantly decreased survival were age greater than 66 years, increased pain, poor performance status, and increasing alkaline phosphatase. Prior radiation therapy was associated with increased drug toxicity, lower doses of chemotherapy, and decreased survival (not significant). There was a significant relationship between the degree of improvement of acid phosphatase, alkaline phosphatase, pain, and performance status to increased survival. Three categories of response were defined based on these parameters. The mean survival of seven patients with partial response (106 weeks) is significantly longer than that of seven with measurable response (57 weeks) and eight with no response (26 weeks). Four patients had severe leukopenia and one died of sepsis. These results compare favorably with previous reports of chemotherapy treatment of advanced prostate cancer.

Acid Phosphatase↗

Vesicant extravasation: myths and realities.

PURPOSE/OBJECTIVES: To provide a comprehensive review of the literature pertinent to the phenomenon of antineoplastic vesicant extravasation within the framework of common misconceptions held by oncology nurses. DATA SOURCES: National guidelines, published articles in professional specialty journals and proceedings, and the authors' clinical experiences in the care of patients receiving vesicant agents. DATA SYNTHESIS: Antineoplastic vesicant extravasation can result in significant morbidity, severely limiting quality of life for patients with cancer. It also is a liability concern for oncology nurses. Many unanswered questions regarding extravasation exist because the phenomenon is difficult to study in humans and actual extravasation injuries are both sporadic and underreported. The incidence of extravasation from vascular access devices is unknown. Similarly, many recommended management strategies are empirically based. Misconceptions about the nature of extravasation injuries and the manner in which they should be managed contribute to poor patient outcomes and increased liability. CONCLUSIONS: The disproval of 10 myths regarding the nature and management of vesicant extravasation is an adjunctive step in the translation of existing national guidelines to workable institutional standards and appropriate professional practice. NURSING IMPLICATIONS: Oncology nurses are in a strategic position to observe the feasibility and efficacy of prevention and management guidelines established at national and local levels. Oncology nurses involved in the administration of antineoplastic vesicant agents are responsible for maintaining a current knowledge base about vesicants and for planning nursing care within the established standards of practice.

Antineoplastic Agents↗

New approaches: innovations in cancer prevention, diagnosis, treatment, and support.

PURPOSE/OBJECTIVE: To discuss and project changes in cancer care in the 21st century. DATA SOURCES: Projections are based on synthesis of multiple scholarly, professional, and governmental information sources. DATA SYNTHESIS: Changes will be reflected in the areas of patient subgrouping for more effective prevention and treatment; a redesigned therapeutic paradigm; a mind-body renaissance emphasizing holism and quality of life; and an accentuated influence of ethics on oncology nursing practice arising from healthcare reform and new scientific understanding of the human gene. CONCLUSIONS: Opportunities for nurses resulting from these changes include roles as genetic-risk analysts, health-education media designers, patient readiness evaluators, technology accessors, partners in a holistic care center, and treatment options advisors. IMPLICATIONS FOR NURSING PRACTICE: Nurses will need to respond to these challenges by expanding their knowledge base with respect to genetics and computer science, refining the interactive skills that are necessary to address the psychosocial aspects of cancer care, and assimilating new technology while designing strategies to minimize the dehumanizing consequences of technology dependency.

Delivery of Health Care↗